Journal
Current Medical Research and Opinion
Publication Date
11-1-2022
Volume
38
Issue
11
First Page
1935
Last Page
1945
Document Type
Open Access Publication
DOI
10.1080/03007995.2022.2112872
Rights and Permissions
Liu J, Emond B, Maiese EM, Lafeuille MH, Lefebvre P, Ghelerter I, Wu C, Hurteau JA, Thaker PH. Real-world utilization and outcomes of systemic therapy among patients with advanced or recurrent endometrial cancer in the United States. Curr Med Res Opin. 2022 Nov;38(11):1935-1945. doi: 10.1080/03007995.2022.2112872. © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Recommended Citation
Liu, Jinan; Emond, Bruno; Maiese, Eric M; Lafeuille, Marie-Hélène; Lefebvre, Patrick; Ghelerter, Isabelle; Wu, Caterina; Hurteau, Jean A; and Thaker, Premal H, "Real-world utilization and outcomes of systemic therapy among patients with advanced or recurrent endometrial cancer in the United States." Current Medical Research and Opinion. 38, 11. 1935 - 1945. (2022).
https://digitalcommons.wustl.edu/oa_4/973
Additional Links
Supplemental material is available for this article at publisher site.
